Literature DB >> 19239481

Risk factors for early primary graft dysfunction after lung transplantation: a registry study.

Catherine L Kuntz1, Denis Hadjiliadis, Vivek N Ahya, Robert M Kotloff, Alberto Pochettino, James Lewis, Jason D Christie.   

Abstract

BACKGROUND: Primary graft dysfunction (PGD) is a leading cause of early morbidity and mortality in lung transplantation. We sought to identify risk factors for PGD using the United Network for Organ Sharing/International Society for Heart and Lung Transplant (UNOS/ISHLT) Registry.
METHODS: A total of 6984 lung transplants between 1994 and 2002 were available for analysis. Potential risk factors were tested for association with PGD and multivariable logistic regression was applied to adjust for confounding.
RESULTS: The overall incidence of PGD was 10.7% (95% CI 9.9-11.4). In multivariable analyses, factors independently associated with PGD were donor age >45 yr (p < 0.001); donor head trauma (p = 0.03); recipient body mass index >25 kg/m(2) (p = 0.005); recipient female gender (p = 0.001); use of Eurocollins preservation solution (p = 0.001); single lung transplant (p = 0.005); increased ischemic time (p < 0.001); and elevated recipient pulmonary artery systolic pressure at transplant (p < 0.001). Recipient transplant diagnosis was strongly associated with PGD, with primary or secondary pulmonary hypertension (p < 0.001 for both), and idiopathic (p < 0.001) or secondary pulmonary fibrosis (p = 0.011) as significant and independent risk factors for PGD.
CONCLUSIONS: Risk factors for PGD in the UNOS/ISHLT registry are consistent with prior smaller studies. Recipient, donor, and therapy variables are independently associated with PGD, as defined in a large registry.

Entities:  

Mesh:

Year:  2009        PMID: 19239481     DOI: 10.1111/j.1399-0012.2008.00951.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  41 in total

1.  In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation.

Authors:  Daniel Kreisel; Ruben G Nava; Wenjun Li; Bernd H Zinselmeyer; Baomei Wang; Jiaming Lai; Robert Pless; Andrew E Gelman; Alexander S Krupnick; Mark J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

2.  CASE 7--2014 Rescue therapy with early extracorporeal membrane oxygenation for primary graft dysfunction after bilateral lung transplantation.

Authors:  Ali M Farooki; Heidi Bazick-Cuschieri; Emily K Gordon; James C Lee; Edward C Cantu; John G Augoustides
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-08-30       Impact factor: 2.628

3.  Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.

Authors:  Mary K Porteous; James C Lee; David J Lederer; Scott M Palmer; Edward Cantu; Rupal J Shah; Scarlett L Bellamy; Vibha N Lama; Sangeeta M Bhorade; Maria M Crespo; John F McDyer; Keith M Wille; A Russell Localio; Jonathan B Orens; Pali D Shah; Ann B Weinacker; Selim Arcasoy; David S Wilkes; Lorraine B Ware; Jason D Christie; Steven M Kawut; Joshua M Diamond
Journal:  Ann Am Thorac Soc       Date:  2017-10

4.  Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury.

Authors:  Kunal J Patel; Qi Cheng; Sarah Stephenson; D Patterson Allen; Changhai Li; Jane Kilkenny; Ryan Finnegan; Valeria Montalvo-Calero; Scott Esckilsen; Chentha Vasu; Martin Goddard; Satish N Nadig; Carl Atkinson
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

5.  Systemic sclerosis and bilateral lung transplantation: a single centre experience.

Authors:  R Saggar; D Khanna; D E Furst; J A Belperio; G S Park; S S Weigt; B Kubak; A Ardehali; A Derhovanessian; P J Clements; S Shapiro; C Hunter; A Gregson; M C Fishbein; J P Lynch Iii; D J Ross; R Saggar
Journal:  Eur Respir J       Date:  2010-03-29       Impact factor: 16.671

6.  Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.

Authors:  J M Diamond; D J Lederer; S M Kawut; J Lee; V N Ahya; S Bellamy; S M Palmer; V N Lama; S Bhorade; M Crespo; E Demissie; J Sonett; K Wille; J Orens; P D Shah; A Weinacker; D Weill; B A Kohl; C C Deutschman; S Arcasoy; A S Shah; J A Belperio; D Wilkes; J M Reynolds; L B Ware; J D Christie
Journal:  Am J Transplant       Date:  2011-08-22       Impact factor: 8.086

7.  Body mass index is associated with the development of acute respiratory distress syndrome.

Authors:  M N Gong; E K Bajwa; B T Thompson; D C Christiani
Journal:  Thorax       Date:  2009-09-21       Impact factor: 9.139

8.  Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation.

Authors:  Rupal J Shah; Joshua M Diamond; Edward Cantu; James C Lee; David J Lederer; Vibha N Lama; Jonathan Orens; Ann Weinacker; David S Wilkes; Sangeeta Bhorade; Keith M Wille; Lorraine B Ware; Scott M Palmer; Maria Crespo; A Russell Localio; Ejigayehu Demissie; Steven M Kawut; Scarlett L Bellamy; Jason D Christie
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

9.  Obesity and underweight are associated with an increased risk of death after lung transplantation.

Authors:  David J Lederer; Jessie S Wilt; Frank D'Ovidio; Matthew D Bacchetta; Lori Shah; Shankari Ravichandran; Jenny Lenoir; Brenda Klein; Joshua R Sonett; Selim M Arcasoy
Journal:  Am J Respir Crit Care Med       Date:  2009-07-16       Impact factor: 21.405

10.  Preoperative echocardiographic-defined moderate-severe pulmonary hypertension predicts prolonged duration of mechanical ventilation following lung transplantation for patients with COPD.

Authors:  Jeremy P Wrobel; Bruce R Thompson; Gregory I Snell; Trevor J Williams
Journal:  Lung       Date:  2012-10-12       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.